• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Neurotech International

Neurotech International

ASX:NTI

  • Home
  • Corporate
    • Board and Management
    • Corporate Directory
    • Corporate Governance
  • Development Programs
    • Biopharmaceutical Trials
    • Combination Therapy
    • Pathways to Commercialisation
    • Mente Technology
  • Investors
    • Investor Dashboard
    • ASX Announcements
    • Company Reports
    • Presentations
    • Research
    • News & Media
  • Contact

The Hemp Gazette

Neurotech Releases ASD Medical Cannabis Study Results

12 July 2022 News & MediaThe Hemp Gazette

Australia’s Neurotech International Limited (ASX: NTI) has announced what it says are successful outcomes of its medical cannabis formulation on key behavioural issues impacting kids with autism.

Australia’s Neurotech Inks Cannabis Cultivation Partnership

11 May 2021 News & MediaThe Hemp Gazette

Neurotech International Limited (ASX:NTI) has established a strategic medical cannabis cultivation partnership with CannaPacific Limited.

Footer

Suite 5 CPC, 145 Stirling Highway
Nedlands WA 6009
Australia

moc.l1660063197anoit1660063197anret1660063197nihce1660063197torue1660063197n@ofn1660063197i1660063197

+61 (8) 9389 3130

Subscribe to our latest announcements

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2022 Neurotech International • Site by White Noise Communications

Download prospectus